Which pharmaceutical product recall in 2004 led to one of the largest FDA regulatory actions and fundamentally changed how we monitor drug safety?

Product recalls in the pharmaceutical industry can have life-or-death consequences and often make headlines. This recall significantly impacted the medical community and patients worldwide, leading to major changes in how drug safety is monitored. Test your knowledge of this influential pharmaceutical recall case that reshaped industry standards.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Vioxx (rofecoxib), withdrawn after being linked to increased risk of heart attacks and strokes
Baycol (cerivastatin), pulled from market due to reports of fatal rhabdomyolysis
Rezulin (troglitazone), removed after causing severe liver damage in patients
Bextra (valdecoxib), withdrawn due to cardiovascular and skin reaction risks